The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Inhibition of cardiomyocytes late INa with ranolazine blunts anthracyclines-cardiotoxicity in experimental models in vitro and in vivo.
Nicola Maurea
No relevant relationships to disclose
Carmela Coppola
No relevant relationships to disclose
Domenica Rea
No relevant relationships to disclose
Giovanna Piscopo
No relevant relationships to disclose
Gennaro Riccio
No relevant relationships to disclose
Antonio Barbieri
No relevant relationships to disclose
Giuseppe Palma
No relevant relationships to disclose
Marianna Gala
No relevant relationships to disclose
Antonio Luciano
No relevant relationships to disclose
Aldo Giudice
No relevant relationships to disclose
Immacolata Capasso
No relevant relationships to disclose
Stefania Scala
No relevant relationships to disclose
Rosario Vincenz Iaffaioli
No relevant relationships to disclose
Claudia De Lorenzo
No relevant relationships to disclose
Claudio Arra
No relevant relationships to disclose
Carlo G. Tocchetti
No relevant relationships to disclose